New drug combo aims to outsmart Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests an experimental drug called OKN4395, taken as a pill, alone or together with the immunotherapy pembrolizumab. The goal is to find a safe dose and see if the combination can shrink tumors in people with advanced solid cancers like lung, colorectal, sto…
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC